117 related articles for article (PubMed ID: 1389506)
21. [Diagnosis and treatment of malignant melanoma].
Ishihara K; Ikegawa S
Gan To Kagaku Ryoho; 1985 Sep; 12(9):1727-34. PubMed ID: 2412493
[TBL] [Abstract][Full Text] [Related]
22. Myelodysplastic syndrome following treatment of malignant melanoma with vincristine, ACNU, and dacarbazine.
Kageshita T; Kuribayashi N; Ono T
J Dermatol; 2000 Mar; 27(3):178-80. PubMed ID: 10774145
[TBL] [Abstract][Full Text] [Related]
23. Combination hepatic arterial infusion therapy is effective for ocular melanoma metastasis to the liver.
Ueda H; Hamagami H; Tanaka H; Kida Y; Ichinose M
Oncol Rep; 2005 Dec; 14(6):1543-6. PubMed ID: 16273253
[TBL] [Abstract][Full Text] [Related]
24. [Control of multiple skin and lung metastasis of malignant melanoma by combined DAV and OK-432 chemoimmunotherapy in association with large-scale administration of indomethacin].
Maeda K; Miura S; Kawamura M; Jimbow K
Gan To Kagaku Ryoho; 1984 Nov; 11(11):2434-7. PubMed ID: 6497401
[TBL] [Abstract][Full Text] [Related]
25. Amelanotic malignant melanoma of the esophagus: report of a patient with recurrence successfully treated with chemoendocrine therapy.
Suzuki Y; Aoyama N; Minamide J; Takata K; Ogata T
Int J Clin Oncol; 2005 Jun; 10(3):204-7. PubMed ID: 15990972
[TBL] [Abstract][Full Text] [Related]
26. [Case of metastatic malignant melanoma responded to combination chemotherapy with DTIC].
Tamura T; Miyamoto H; Harada M; Makinoya T; Yamamoto M; Miyoshi Y; Komi N
Gan To Kagaku Ryoho; 1984 Feb; 11(2):327-32. PubMed ID: 6582806
[TBL] [Abstract][Full Text] [Related]
27. [Treatment of malignant melanoma: recent advances and perspectives].
Saida T
Gan To Kagaku Ryoho; 1997 Jan; 24(1):10-5. PubMed ID: 9020939
[TBL] [Abstract][Full Text] [Related]
28. Our experience with interferon alpha: metastatic malignant melanoma.
Merimsky O; Chaitchik S
Mol Biother; 1992 Sep; 4(3):135-8. PubMed ID: 1445667
[TBL] [Abstract][Full Text] [Related]
29. [Malignant melanoma in Japan: unique distribution and effect of DAV chemoimmunotherapy (part II)].
Ishihara K; Hayasaka K; Ikeda S; Terakado T; Kukita A; Seki Y; Jimbow K; Suzuki M
Gan To Kagaku Ryoho; 1984 Mar; 11(3):467-73. PubMed ID: 6703721
[TBL] [Abstract][Full Text] [Related]
30. Dacarbazine (DTIC) and human recombinant interferon alpha 2a (Roferon) in the treatment of disseminated malignant melanoma.
Mulder NH; Willemse PH; Schraffordt Koops H; de Vries EG; Sleijfer DT
Br J Cancer; 1990 Dec; 62(6):1006-7. PubMed ID: 2257203
[No Abstract] [Full Text] [Related]
31. A case of malignant melanoma that developed multiple metastases after switching from interferon-beta to pegylated interferon-alpha-2b as adjuvant therapy.
Fukumoto T; Fujiwara S; Sakaguchi M; Oka M; Nishigori C
Eur J Dermatol; 2018 Feb; 28(1):115-116. PubMed ID: 29171409
[No Abstract] [Full Text] [Related]
32. Interferon alpha-2a and dacarbazine in melanoma.
Kirkwood JM; Ernstoff MS; Giuliano A; Gams R; Robinson WA; Costanzi J; Pouillart P; Speyer J; Grimm M; Spiegel R
J Natl Cancer Inst; 1990 Jun; 82(12):1062-3. PubMed ID: 2189999
[No Abstract] [Full Text] [Related]
33. [Malignant melanoma of the alimentary tract].
Nakamura T; Ide H
Gan To Kagaku Ryoho; 2003 May; 30(5):619-25. PubMed ID: 12795092
[TBL] [Abstract][Full Text] [Related]
34. Melanocytoma in the orbital apex.
Sato K; Kubota T; Kodera T; Kitai R; Takeuchi H; Yoshida K
J Neurooncol; 2009 Mar; 92(1):107-10. PubMed ID: 18949444
[TBL] [Abstract][Full Text] [Related]
35. Postoperative DAV-IFN-β therapy does not improve survival rates of stage II and stage III melanoma patients significantly.
Matsumoto T; Yokota K; Sawada M; Sakakibara A; Shibata S; Yasue S; Tomita Y; Yatsuya H; Akiyama M
J Eur Acad Dermatol Venereol; 2013 Dec; 27(12):1514-20. PubMed ID: 23198869
[TBL] [Abstract][Full Text] [Related]
36. Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD) plus interferon alpha for metastatic melanoma: a multicentre phase II study.
Punt CJ; van Herpen CM; Jansen RL; Vreugdenhil G; Muller EW; de Mulder PH
Br J Cancer; 1997; 76(2):266-9. PubMed ID: 9231931
[TBL] [Abstract][Full Text] [Related]
37. Phase II study of interferon alfa-2a and dacarbazine in advanced melanoma. Biological Response Modifiers in Melanoma (BREMIM) Italian Cooperative Group.
Eur J Cancer; 1992; 28A(10):1719-20. PubMed ID: 1389493
[TBL] [Abstract][Full Text] [Related]
38. Primary malignant melanoma of the esophagus associated with adenocarcinoma of the lung.
Yano M; Shiozaki H; Murata A; Inoue M; Tamura S; Taniguchi M; Monden M
Surg Today; 1998; 28(4):405-8. PubMed ID: 9590706
[TBL] [Abstract][Full Text] [Related]
39. The CD4+/CD8+ ratio as a prognostic factor in patients with metastatic melanoma receiving chemoimmunotherapy.
Hernberg M; Muhonen T; Turunen JP; Hahka-Kemppinen M; Pyrhönen S
J Clin Oncol; 1996 May; 14(5):1690-6. PubMed ID: 8622089
[TBL] [Abstract][Full Text] [Related]
40. Response of subcutaneous and cutaneous metastases of malignant melanoma to combined cytostatic plus interferon therapy.
Hahka-Kemppinen M; Muhonen T; Virolainen M; Jekunen A; Asko-Seljavaara S; Pyrhönen S
Br J Dermatol; 1995 Jun; 132(6):973-7. PubMed ID: 7544996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]